Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis

Moritz Hadwiger, Nikolaos Dagres, Gerhard Hindricks, Helmut L'hoest, Ursula Marschall, Alexander Katalinic, Fabian-Simon Frielitz


Introduction: This study investigates the runtime and costs of biventricular defibrillators (CRT-D) and biventricular pacemakers (CRT-P). Accurate estimates of cardiac resynchronization therapy (CRT) device runtime across all manufactures are rare, especially for CRT-P. Methods: Health claims data of a large nationwide German health insurance was used to analyze CRT device runtime. We defined device runtime as the time between the date of implantation and the date of generator change or removal. The median costs for implantation, change, and removal of a CRT device were calculated accordingly. Results: In total, the data set comprises 17,826 patients. A total of 4,296 complete runtimes for CRT-D devices and 429 complete runtimes for CRT-P devices were observed. Median device runtime was 6.04 years for CRT-D devices and 8.16 years for CRT-P devices (log-rank test p<0.0001). The median cost of implantation for a CRT-D device was 14,270 EUR, and for a CRT-P device 9,349 EUR. Conclusions: Compared to CRT-P devices, CRT-D devices had a significantly shorter device runtime of about two years. Moreover, CRT-D devices were associated with higher cost. The study provides important findings that can be utilized by cost-effectiveness analyses.

ZeitschriftGerman medical science : GMS e-journal
Seiten (von - bis)Doc02
PublikationsstatusVeröffentlicht - 2022

Strategische Forschungsbereiche und Zentren

  • Profilbereich: Zentrum für Bevölkerungsmedizin und Versorgungsforschung (ZBV)


Untersuchen Sie die Forschungsthemen von „Device runtime and costs of cardiac resynchronization therapy pacemakers - a health claims data analysis“. Zusammen bilden sie einen einzigartigen Fingerprint.